Karen Prange, Director at AtriCure, Inc. (ATRC), sold 3,000 shares at $28.65 ($86K) on 2026-05-20, disclosed to the SEC on 2026-05-22.
Seasonal sale ($86k) by Director — this insider has traded ATRC in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| ATRC | SELL | 2023-06-12 | $34K | — | Filing → |
| VRAY | BUY | 2022-05-12 | $100K | — | Filing → |